GAIN THERAPEUTICS INC (GANX)

US36269B1052 - Common Stock

1.57  +0.01 (+0.64%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to GANX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.55. This target is 380.76% above the current price.
GANX was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about GANX.
In the previous month the buy percentage consensus was at a similar level.
GANX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 1.575.058.167.5510.50 - 221.66% 419.75% 380.76% 568.79%
Up and Down Grades
Date Firm Action Rating
2024-12-05 Roth MKM Initiate Buy
2024-11-25 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-09 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-09 Chardan Capital Maintains Buy -> Buy
2024-07-11 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-02 HC Wainwright & Co. Maintains Buy -> Buy
2024-05-31 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-28 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-25 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-23 Oppenheimer Maintains Outperform -> Outperform
2024-04-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-27 Chardan Capital Reiterate Buy -> Buy
2023-12-04 HC Wainwright & Co. Maintains Buy -> Buy
2023-09-18 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-12 Maxim Group Initiate Buy
2023-08-31 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-14 Chardan Capital Reiterate Buy -> Buy
2023-08-14 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-12 Oppenheimer Reiterate Outperform -> Outperform
2023-05-15 Chardan Capital Maintains Buy -> Buy
2023-05-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-01 HC Wainwright & Co. Reiterate Buy
2023-03-27 Chardan Capital Maintains Buy
2022-12-09 Chardan Capital Initiate Buy
2022-11-25 Oppenheimer Maintains Outperform
2022-11-14 BTIG Maintains Buy
2022-11-14 HC Wainwright & Co. Maintains Buy